Problems of development of telemedicine technologies in Russia through the prism of foreign experience

Author:

Kobyakova O. S.1ORCID,Kadyrov F. N.1ORCID

Affiliation:

1. Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Abstract

The use of telemedicine technologies in the Russian Federation has been allowed legally only since 2018. Such a small experience is objectively insufficient for a development of a serious practice of using telemedicine technologies. Given the global trend of unification of medical and information technologies, it would be illogical to ignore the experience of foreign countries, in many of which the right to use telemedicine technologies was secured earlier than in the Russian Federation and experience has been gained in solving a number of problems arising in this area. Moreover, a detailed analysis allows us to identify the main emerging trends in this area.A review of foreign practice shows that most countries have followed the path of both legislative regulation of the use of telemedicine technologies, and more detailed regulation in the standards of medical care or similar documents. Moreover, in many cases, this regulation is carried out by medical associations or insurance companies. This is especially true for the United States. The experience of this country is also interesting because each state has its own legislation in the field of telemedicine technologies, reflecting different approaches to solving emerging problems.

Publisher

Sechenov University

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3